Bed Bath & Beyond Drops

Bed Bath & Beyond Drops

Bed Bath & Beyond shares dropped over 11% to the lowest since June 2009 on Friday after the omnichannel retailer reported late Thursday a worse-than-expected decline in its fiscal Q1 earnings. The new 52-week range is $29.59 to $48.83. EPS decreased to $0.53 for the three months ended May 27, including $0.05 per share related to an unfavorable impact from new share-based accounting, down from $0.80, a year ago. That […]

Read More ˃
Amec Foster Wheeler Gets Contract

Amec Foster Wheeler Gets Contract

Amec Foster Wheeler said Friday it has won an engineering procurement and construction contract from Gruyere Management Pty Ltd worth AUD298 million ($226.8 million) for the Gruyere gold project. The contract will be jointly executed by Amec Foster and Civmec Construction and Engineering as a joint venture, according to a statement Friday. The project, located about 200 kilometres east of Laverton, in Western Australia, is one of the largest undeveloped […]

Read More ˃
Zosano Pharma Presents Positive Data From Zotrip Study

Zosano Pharma Presents Positive Data From Zotrip Study

Zosano Pharma presented data on Saturday from its phase 2/3 Zotrip study for the acute treatment of migraines during the annual meeting of the American Headache Society in Boston. Data showed that the 3.8mg dose of M207 achieved both co-primary endpoints of pain freedom and most bothersome symptom freedom at 2 hours. In addition, the 3.8mg dose achieved significance in the secondary endpoints of pain freedom at 45 minutes and […]

Read More ˃
Achaogen Presents Data

Achaogen Presents Data

Achaogen presented data that demonstrated the potential of plazomicin against multi-drug resistant gram-negative bacteria at the American Society for Microbiology meeting currently being held in New Orleans. The Care trial presentation described the reduced mortality in patients with bloodstream infections receiving plazomicin compared to colistin at day 28 and through long term follow-up at day 60. Additionally, the company noted just prior to the meeting that the U.S. Food and […]

Read More ˃
Orbital ATK Wins Contract

Orbital ATK Wins Contract

Orbital ATK, a provider of aerospace and defense technologies, said Tuesday that it has obtained an initial $90 million contract from Northrop Grumman (NOC) to produce composite components for the B-2 Spirit stealth bomber with an option for follow-on orders. Under the terms of the 5-year contract, Orbital ATK will perform “non-recurring engineering” and produce 17 “hot trailing edge” composite parts. Production will take place at Orbital ATK’s Aerospace Structures […]

Read More ˃